Sharps Technology, Inc. (STSS)
Sharps Technology, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Sharps Technology, Inc. (STSS) is a Medical - Instruments & Supplies company based in US with a market capitalization of $77.9M. Free cash flow was negative at -$16.7M. This page tracks STSS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 55 employees · IPO Apr 14, 2022
Valuation
Valuation & price
$1.88 · as of May 17, 2026 · -88.3% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
0.29
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$77.9M
Market cap
—
Revenue growth (YoY)
-202.5%
Gross margin
-$16.7M
Free cash flow (USD)
-$7.3M
Net debt
Net cash position
604286.1%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2019 → 2025
Free cash flow by year
2019 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: —
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Sharps Technology, Inc.'s market cap?
Sharps Technology, Inc. (STSS) has a market capitalization of $77.9M.
What is STSS's P/E ratio?
A meaningful P/E ratio is not available for STSS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is STSS's price-to-book (P/B) ratio?
STSS trades at 0.29 times book value per share.
Are insiders buying STSS stock?
SEC Form 4 filings show no open-market insider buys at Sharps Technology, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Medical - Instruments & Supplies
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.